The prevalence of skin disease in HIV infection

AIDS Patient Care and STDs

Volumn 12, Issue 11, 1998, Pages 849-852

  Darley, Charles ^a,b  

^a Hove Nuffield Hospital   (United Kingdom)

^b BRIGHTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FOSCARNET; GANCICLOVIR; LAMIVUDINE; RITONAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CASE REPORT; CONFERENCE PAPER; GRANULOMA ANNULARE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; MALE; MYCOBACTERIUM KANSASII; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; PREVALENCE; SKIN BIOPSY; SKIN INFECTION; TOPICAL DRUG ADMINISTRATION;

EID: 0031756494     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.1998.12.849     Document Type: Conference Paper

References (4)

1. + cell count. Dermatology 1996;192:325-328.
2. Schaub N, Gilli L, Rufli T, et al. Epidemiology of skin diseases in HIV-infected patients: A prospective cohort study. Schweiz Rundsch Med Prax 1996;85:1162-1166.
3. Breathnach A, Levell N, Munro C, Natarajan S, Pedler S. Cutaneous Mycobacterium kansasii infection: Case report and review. Clin Infect Dis 1995;20:812-817.
4. Uthayakumar S, Nandwani R, Drinkwater T, Nayagam A, Darley C. The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression. Br J Dermatol 1997;137:595-598.